The regulator said market authorisation was conditional to submission of ongoing clinical trial data and safety data of the vaccine, at longer time intervals. All vaccinations have to be recorded on the CoWIN platform and all adverse events have to be strictly monitored. Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin on Thursday received … Read more
The Subject Expert Committee on Wednesday had recommended an upgrade the status of Covishield and Covaxin from restricted use in emergencies to grant of new drug permission with conditions in the adult population. The Drugs Controller General of India (DCGI) will take a final decision on granting market approval to two Covid-19 vaccines in the … Read more
The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night. The cumulative COVID-19 vaccine doses administered in the country have reached 158.74 crore so far, the Union Health Ministry said on Tuesday. A total of 3,70,32,672 doses have been given to adolescents in the … Read more
Serum Institute of India (SII), on October 25, had applied to the Drugs Controller General of India (DCGI) seeking regular market authorization for the vaccine. Over 100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI which had sought … Read more
Jameel, the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia, said there is no data for the other combinations of vaccines as of now. Of the vaccines against COVID-19 approved in India, Covovax would be a better booster for those who were administered Covishield jabs than another dose of the same … Read more
The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night, the ministry said. The cumulative number of COVID-19 vaccine doses administered in the country reached 143 crore on Tuesday, the Union health ministry said. More than 57 lakh (57,76,358) vaccine doses have been administered … Read more
The decisions came amid rising Covid cases linked to the Omicron variant of the virus. Bharat Biotech’s Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said. Also, healthcare and frontline workers and citizens … Read more
If and when the recommendation for a booster is made, beneficiaries vaccinated with Covishield, Sputnik V, and are likely to have multiple options. (File) A Covid-19 booster dose, when administered, should be of a vaccine based on a different platform than the first two doses, according to preliminary consensus reached by India’s top technical advisory … Read more
Bharat Biotech will add additional countries to its list of Covaxin export destinations in December as more countries grant emergency-use approvals. (File) After Serum Institute of India, Bharat Biotech on Monday said it had begun exports of its Covid-19 vaccine Covaxin. The World Health Organization (WHO) earlier this month granted the India-made jab emergency-use approval. … Read more
Covaxin is a Vero cell-derived, inactivated whole-virion vaccine formulated with a novel adjuvant Bharat Biotech’s Covaxin is 50 per cent effective as a vaccine against symptomatic Covid-19 infection, says a study conducted on AIIMS, New Delhi hospital workers during the second wave surge in India. The study, first of its kind of the effectiveness of … Read more